BIOtinidase Test In Optic-Neuropathy
Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusCompleted
Sponsors
Fondation Ophtalmologique Adolphe de Rothschild
CLINICAL TRIAL: NCT03268681
BioSeek: nct03268681
Keywords
Abstract
Biotinidase is an enzyme that recycles biotin, a water-soluble vitamin essential as a coenzyme for four carboxylases that are involved in gluconeogenesis, fatty acid synthesis, and in the catabolism of several branch-chain amino acids. Biotinidase deficiency (BD) is an autosomal recessively inherited disorder. Patients with profound BD (<10% of mean normal serum biotinidase activity) presents, usually during early childhood, with neurological (seizures, hypotonia, ataxia, developmental delay, vision problems, and/or hearing loss) and non-neurological findings (metabolic acidosis, respiratory difficulties, alopecia and/or skin rash) that may progress to coma or death if untreated.
Three cases of adult-onset biotinidase deficiency with reversible optic neuropathy have recently been described in France, where there is no neonatal screening of BP. Once treated with Biotin, patients' vision was fully restored.
This study aims to assess the prevalence of BP among a population of patients with idiopathic optic neuropathy, and to assess the efficacy of Biotin supplementation on visual impairment in these patients.
Dates
| Last Verified: | 09/30/2018 |
| First Submitted: | 08/28/2017 |
| Estimated Enrollment Submitted: | 08/29/2017 |
| First Posted: | 08/30/2017 |
| Last Update Submitted: | 10/16/2018 |
| Last Update Posted: | 10/17/2018 |
| Actual Study Start Date: | 07/25/2017 |
| Estimated Primary Completion Date: | 05/29/2018 |
| Estimated Study Completion Date: | 07/25/2018 |
Condition or disease
Biotin Deficiency
Optic Neuropathy
Phase
-
Eligibility Criteria
| Sexes Eligible for Study | All |
| Sampling method | Non-Probability Sample |
| Accepts Healthy Volunteers | Yes |
| Criteria | Inclusion Criteria: - patient with bilateral optic neuropathy - symptoms beginning before 50 years old - diagnosed for more than 1 months - etiology unknown Exclusion Criteria: - none |
Outcome
Primary Outcome Measures
1. prevalence of biotin deficiency among patients with idiopathic optic neuropathy [baseline]
measure of biotinidase activity (nkat/l unit)
